AKT2 Inhibition of Cisplatin-induced JNK/p38 and Bax Activation by Phosphorylation of ASK1

This publication has 46 references indexed in Scilit:

• Ovarian cancer: progress and continuing controversies in management
  European Journal Of Cancer, 2002
• The Phosphoinositide 3-Kinase Pathway
  Science, 2002
• Regulation of Cell Death Protease Caspase-9 by Phosphorylation
  Science, 1998
• Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
  Science, 1997
• Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
  Nature, 1995
• The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
  Cell, 1995
• Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53
  Nucleic Acids Research, 1994
• High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.
  Proceedings of the National Academy of Sciences, 1992
• Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.
  Journal of Clinical Investigation, 1991
• Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
  Biochemical Pharmacology, 1985